Eli Lilly (LLY 0.10%) stock eked out a gain on the stock market Wednesday, but the company doesn't necessarily have itself to thank for this. One of its rival pharmaceutical companies posted strong annual results fueled largely by a product category Lilly is entering. That pushed Eli Lilly's share price marginally higher (by 0.1%), handily beating the 1.6% decline of the S&P 500 index.The Novo Nordisk effectThat rival was Danish pharmaceutical company Novo Nordisk (NVO 5.25%), which published its full-year ...

KKStock As I have written regarding Eli Lilly and Company (NYSE:LLY) beginning in August 2023, I expect the GLP-1 drugs to become the largest sell pharmaceutical class ever, with US sales of $150 billion in 2030. I recently listened to a Grand Rounds presentation on the GLP-1s given at a major medical center. I shall discuss the key comments, which I found to be very useful in understanding both the history of incretins as well as the multi-faceted benefits of this revolutionary drug class. The GLP-1 hor ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Over the past month, shares of this drugmaker have returned +8.9%, compared to the Zacks S&P 500 composite's +3.3% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which Lilly falls in, has gained 5.7%. The key question now is: What could be the stock's future direction?While media releases or rumo ...

A pharmacist displays boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023.Norway's giant wealth fund, the world's largest, touted the possibility that Danish drugmaker Novo Nordisk and U.S. rival Eli Lilly could be on course to become the first healthcare members of the trillion-dollar club.The comments come as the two companies are seen as the primary beneficiaries of skyrocketing demand for diabe ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Eli Lilly (LLY) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Lilly currently has an average brokerage recommendation (ABR) o ...

Eli Lilly (LLY) ended the recent trading session at $645, demonstrating a +0.9% swing from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.76% for the day. At the same time, the Dow added 0.59%, and the tech-heavy Nasdaq gained 1.12%.Prior to today's trading, shares of the drugmaker had gained 9.66% over the past month. This has outpaced the Medical sector's gain of 1.57% and the S&P 500's gain of 2.5% in that time.Analysts and investors alike will be keeping ...

Eli Lilly & Co (NYSE: LLY) is in the green this morning following a report that it’s in talks with Germany to have its weight-loss drug be included in the country’s public health coverage.Lilly is ‘optimistic’ on discussions with GermanyCopy link to sectionIlya Yuffa – president of Lilly International told Spiegel magazine today that the pharmaceutical behemoth is in “good dialogue” with the German government. I’m optimistic that we can come to an agreement.The news arrives only days before the New York lis ...

Microsoft, Apple, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla -- a group that Bank of America analyst Michael Hartnett dubbed the "Magnificent Seven," -- have taken the market by storm for an incredible outperformance in 2023 and a sustained run so far in 2024.But what about the market's most valuable non-tech-focused companies?Interestingly enough, if you look at the highest weighted companies in the S&P 500, it is dominated by the Magnificent Seven and Broadcom, a semiconductor company. After that ...

The six most valuable companies in the world by market cap all have one thing in common: each is valued at over $1 trillion. Five of the six are in the technology business, with the exception being Saudi Arabian Oil.With a market cap of roughly $592 billion, Eli Lilly (LLY 1.85%) is the world's largest healthcare company and the 10th most valuable business in the world.Indeed, Lilly stock has been on a tear lately. In just the last year, the stock has returned nearly 80% -- about triple the return of the S& ...

Barely four years ago, El Lilly (NYSE:LLY) was trading at just around $130. Fast forward, the stock trades at a whopping $627, having recently rubbed a new record price above $645. That represents a price increase of nearly 400%. The return in the past year is also quite impressive at 80%. And guess what? El Lilly is now more valuable than EV giant Tesla Inc (NASDAQ:TSLA).Boasting a market cap of $595.80 billion, El Lilly is undeniably a rising giant in the stock market. Thanks to Tesla’s recent declines in ...